Paul Farrell Jr. is one of the attorneys representing the plaintiffs. He says he feels like they could have held the trial this month safely.
“We feel like Charlie Brown trying to kick the football,” Farrell said. “Obviously we respect the COVID epidemic, but we should fear the opioid epidemic. There are still people suffering and dying every day in West Virginia.”
States Seek $26.4 Billion From Drug Companies in Opioid Litigation
This article was originally published in The Wall Street Journal. Higher settlement demand comes as trial dates in Ohio and West Virginia add urgency to talks
Area residents, leaders to testify on the impact of the opioid crisis
The purpose of this phase of discovery is to allow the defendants to hear first-hand the impact on public health and the safety of our community.
National Prescription Opiate Litigation
Paul Farrell, Jr. is widely recognized by his peers as a pioneer and authority on the diversion claims directed against the opiate prescription drug manufacturers, distributors and dispensers.
Supply-side economics: the vicious cycle of the opioid epidemic
Supply side economics is premised on the idea that “supply creates it own demand.” This certainly holds true for prescription opioids.
Transparency: The revelation of the ARCOS data.
Our mission in the opioid litigation was to bring transparency to the volume of prescription opiates sold into our communities across the country.
$10 Million Medical Malpractice Verdict
Riggs v. West Virginia University Health
The Tribune: $1.25B West Virginia Opioid Settlement Trial Date Set
This article was originally published in The Tribune.
From ABC News: $1.25B West Virginia opioid settlement trial date set
West Virginia communities seeking a $1.25 billion settlement with the opioid industry are set to go on trial against the companies in late August
KOB4 Eyewitness News: $1.25B West Virginia Opioid Settlement Trial Date Set
This article was originally published in KOB4 Eyewitness News.